Drug intelligence / Profile preview

Minggu Fen Jiaonang

Development stage: Unknown
Lead developer: Jilin Fukang Pharmaceutical
Administration: Oral

Overview

Minggu Fen Jiaonang is an oral health supplement developed and manufactured by Jilin Fukang Pharmaceutical. The product is primarily composed of shark cartilage powder, which is naturally rich in glycosaminoglycans such as chondroitin sulfate, as well as essential minerals including calcium and phosphorus. In the Chinese regulatory landscape, it is classified as a health food (保健食品), often referred to as a Blue Hat product. It is marketed for its potential to support bone and joint health by providing the structural building blocks necessary for cartilage maintenance and bone density. The supplement is intended for individuals seeking nutritional support for skeletal integrity and joint mobility.

Brand names: 明骨粉胶囊
Other names: Minggu Powder CapsulesShark Cartilage Powder Capsules

Beyond the preview

Go deeper on Minggu Fen Jiaonang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Minggu Fen Jiaonang.

Explore the full profile